Aytac HM, Oyaci Y, Pehlivan M, Pehlivan S (2021) DNA Methylation Pattern of Gene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish Patients Diagnosed with Schizophrenia
Avramopoulos D, Pearce BD, McGrath J, Wolyniec P, Wang R, Eckart N et al (2015) Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. PLoS ONE 10(3):e0116696
Aytac HM, Yazar MS, Erol A, Pehlivan S (2021) Investigation of inflammation related gene polymorphism of the mannose-binding lectin 2 in schizophrenia and bipolar disorder. Neurosci J 26(4):346–356
Aytac HM, Oyaci Y, Yazar MS, Pehlivan S (2021) Macrophage migration inhibitory factor-173 G/C polymorphism is associated with the age of onset and insight in Schizophrenia in the Turkish population. Neurol Res 43(12):977–984
Nursal AF, Aytac HM, Ciftci HS, Sila M, Oyaci Y, Pehlivan M et al (2021) TNF-α-308 G/A variant may be associated with bipolar disorder in a Turkish population. Arch Clin Psychiatry (São Paulo) 47:176–179
Aytac HM, Ozdilli K, Tuncel FC, Pehlivan M, Pehlivan S (2020) Tumor necrosis factor-alpha (TNF-α) −238 G/A polymorphism is associated with the treatment resistance and attempted suicide in Schizophrenia. Immunol Investig 51(2):368–380. https://doi.org/10.1080/08820139.2020.1832115
Pehlivana S, Aytacb HM, Ciftcia HS, Oyacia Y, Pehlivanc M, Nursal AF (2020) Investigating the eNOS and IFN-γ gene variants susceptible to bipolar disorder or Schizophrenia in a Turkish cohort. Psychiatry Clin Psychopharmacol 30(4):354–361
Aytac HM, Pehlivan S, Pehlivan M, Oyaci Y (2022) Quantitative detection of methylated SOCS-1 in schizophrenia and bipolar disorder considering SOCS-1 -1478CA/del polymorphism and clinical parameters. Irish J Med Sci (1971 -). https://doi.org/10.1007/s11845-022-03030-w
Kim Y-K, Jung H-G, Myint A-M, Kim H, Park S-H (2007) Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 104(1–3):91–95
García-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Martínez-Cengotitabengoa M, Pina-Camacho L et al (2014) Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull 40(2):376–387
Reale M, Costantini E, Greig NH (2021) Cytokine imbalance in schizophrenia. From research to clinic: potential implications for treatment. Front Psychiatry. https://doi.org/10.3389/fpsyt.2021.536257
Arend WP, Malyak M, Guthridge CJ, Gabay C (1998) Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16(1):27–55
Katila H, Hänninen K, Hurme M (1999) Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4(2):179–181
Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN* 2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47(3):195–198
Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO et al (2013) Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 145(1–3):36–42
Kim S, Lee H, Koo H, Kim J, Song J, Kim M et al (2004) Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder. Psychiatr Genet 14(3):165–167
Zanardini R, Bocchio-Chiavetto L, Scassellati C, Bonvicini C, Tura GB, Rossi G et al (2003) Association between IL-1β-511C/T and IL-1RA (86bp) n repeats polymorphisms and schizophrenia. J Psychiatr Res 37(6):457–462
Watanabe Y, Nunokawa A, Kaneko N, Muratake T, Koizumi M, Someya T (2007) Lack of association between the interleukin-1 gene complex and schizophrenia in a Japanese population. Psychiatry Clin Neurosci 61(4):364–369
Hosseini S, Taheri M, Hosseni-khah Z, Hajilooi M, Mazaheri Z (2013) Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on bipolar disorder. Neuropsychobiology 67(2):116–121
Kubo M, Yamashita M, Abe R, Tada T, Okumura K, Ransom JT et al (1999) CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation. J Immunol 163(5):2432–2442
Coffman R, Ohara J, Bond M, Carty J, Zlotnik A, Paul W (1986) B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 136(12):4538–4541
Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D et al (1988) IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 140(12):4193–4198
Mout R, Willemze R, Landegent J (1991) Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res 19(13):3763
Elghoroury EA, Fadel FI, Farouk H, Elshamaa MF, Kamel S, Kandil D, Mahmoud E (2018) Association of variable number tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in children. Egypt J Med Human Genet 19(3):191–195. https://doi.org/10.1016/j.ejmhg.2017.08.009
Munkholm K, Braüner JV, Kessing LV, Vinberg M (2013) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 47(9):1119–1133. https://doi.org/10.1016/j.jpsychires.2013.05.018
Şimşek Ş, Yıldırım V, Çim A, Kaya S (2016) Serum IL-4 and IL-10 levels correlate with the symptoms of the drug-naive adolescents with first episode, early onset schizophrenia. J Child Adolesc Psychopharmacol 26(8):721–726
Association WM (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194
Vasudevan R, Norhasniza M, Patimah I (2011) Association of variable number of tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in Malaysian patients. Genet Mol Res 10(2):943–947
Singh M, Mansuri M, Jadeja S, Marfatia Y, Begum R, Mansuri MS et al (2018) Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population. Indian J Dermatol Venereol Leprol. https://doi.org/10.4103/ijdvl.IJDVL_1_17
Lee W-C, Wang L-Y (2008) Simple formulas for gauging the potential impacts of population stratification bias. Am J Epidemiol 167(1):86–89
Mata I, Crespo-Facorro B, Pérez-Iglesias R, Carrasco-Marín E, Arranz MJ, Pelayo-Terán JM et al (2006) Association between the interleukin-1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment. Am J Med Genet B Neuropsychiatr Genet 141(8):939–943
Chowdari KV, Xu K, Zhang F, Ma C, Li T, Xie BY et al (2001) Immune related genetic polymorphisms and schizophrenia among the Chinese. Hum Immunol 62(7):714–724
Alvarez-Rodriguez L, Carrasco-Marin E, Lopez-Hoyos M, Mata C, Fernandez-Prieto L, Ruiz-Soto M et al (2009) Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: association of IL-1RN* 2/2 genotype with polymyalgia rheumatica. Hum Immunol 70(1):49–54
Rezaii AA, Hoseinipanah SM, Hajilooi M, Rafiei AR, Shikh N, Haidari M (2009) Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke. Immunol Invest 38(3–4):220–230
Chourasia D, Achyut B, Mittal S, Mittal RD, Ghoshal UC (2009) Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B−511*T/IL-1RN*1 (T1) Haplotype may protect against the disease. Am J Gastroenterol 104(11):2704–2713. https://doi.org/10.1038/ajg.2009.382
Luheshi NM, Kovács KJ, Lopez-Castejon G, Brough D, Denes A (2011) Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues. J Neuroinflammation 8(1):1–5
Meisenzahl EM, Rujescu D, Kirner A, Giegling I, Kathmann N, Leinsinger G et al (2001) Association of an interleukin-1β genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 158(8):1316–1319
Papiol S, Rosa A, Gutierrez B, Martin B, Salgado P, Catalan R et al (2004) Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet 41(3):219–223
Talaei A, Afzaljavan F, Talaei A (2021) IL-1α, IL-1β and IL-1RN haplotypes are associated with bipolar I disorder and its characteristics: a pilot case-control study. Meta Gene 30:100977
Papiol S, Molina V, Desco M, Rosa A, Reig S, Sanz J et al (2008) Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13). Genes Brain Behav 7(7):796–801
Kalkan G, Karakus N, Baş Y, Takçı Z, Özuğuz P, Ateş Ö et al (2013) The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population. Gene 527(2):565–569
Basol N, Celik A, Karakus N, Ozsoy SD, Yigit S (2014) The evaluation of angiotensin-converting enzyme (ACE) gene I/D and IL-4 gene intron 3 VNTR polymorphisms in coronary artery disease. In Vivo 28(5):983–987
Basol N, Inanir A, Yigit S, Karakus N, Kaya SU (2013) High association of IL-4 gene intron 3 VNTR polymorphism with diabetic peripheral neuropathy. J Mol Neurosci 51(2):437–441
Yigit S, Inanir A, Tekcan A, Tural E, Ozturk GT, Kismali G et al (2014) Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis. Gene 537(1):6–9
Karakus N, Yigit S, Kurt GS, Cevik B, Demir O, Ates O (2013) Association of interleukin (IL)-4 gene intron 3 VNTR polymorphism with multiple sclerosis in Turkish population. Hum Immunol 74(9):1157–1160
Kalkan G, Yigit S, Karakus N, Baş Y, Seçkin HY (2013) Association between interleukin 4 gene intron 3 VNTR polymorphism and recurrent aphthous stomatitis in a cohort of Turkish patients. Gene 527(1):207–210
Pérez-Suárez TG, Gutiérrez-Robledo LM, Ávila-Funes JA, Acosta JL, Escamilla-Tilch M, Padilla-Gutiérrez JR et al (2016) VNTR polymorphisms of the IL-4 and IL-1RN genes and their relationship with frailty syndrome in Mexican community-dwelling elderly. Aging Clin Exp Res 28(5):823–832
Bid H, Konwar R, Agrawal C, Banerjee M (2008) Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian J Med Sci 62(7):259–266
Paunio T, Ekelund J, Varilo T, Parker A, Hovatta I, Turunen JA et al (2001) Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet 10(26):3037–3048
Schwab S, Hallmayer J, Albus M, Lerer B, Eckstein G, Borrmann M et al (2000) A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry 5(6):638–649
Schwarz MJ, Krönig H, Riedel M, Dehning S, Douhet A, Spellmann I et al (2006) IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 256(2):72–76
Jun TY, Lee KU, Pae CU, Chae JH, Bahk WM, Kim KS et al (2003) Polymorphisms of interleukin-4 promoter and receptor gene for schizophrenia in the Korean population. Psychiatry Clin Neurosci 57(3):283–288
Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’Anna M, Mascarenhas M, Vargas AE et al (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116(3):214–217
Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiat 74(1):15–25
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)
